Caveolin‐1 tumor‐promoting role in human melanoma

Caveolin‐1 (Cav‐1), a member of the caveolin family, regulates caveolae‐associated signaling proteins, which are involved in many biological processes, including cancer development. Cav‐1 was found to exert a complex and ambiguous role as oncogene or tumor suppressor depending on the cellular microenvironment. Here we investigated Cav‐1 expression and function in a panel of melanomas, finding its expression in all the cell lines. The exception was the primary vertical melanoma cell line, WM983A, characterized by the lack of Cav‐1, and then utilized as a recipient for Cav‐1 gene transduction to address a series of functional studies. The alleged yet controversial role of phospho (Ph)‐Cav‐1 on cell regulation was also tested by transducing the nonphosphorylatable Cav‐1Y14A mutant. Wild‐type Cav‐1, but not mutated Cav‐1Y14A, increased tumorigenicity as indicated by enhanced proliferation, migration, invasion and capacity of forming foci in semisolid medium. Accordingly, Cav‐1 silencing inhibited melanoma cell growth reducing some of the typical traits of malignancy. Finally, we detected a secreted fraction of Cav‐1 associated with cell released microvesicular particles able to stimulate in vitro anchorage independence, migration and invasion in a paracrine/autocrine fashion and, more important, competent to convey metastatic asset from the donor melanoma to the less aggressive recipient cell line. A direct correlation between Cav‐1 levels, the amount of microvesicles released in the culture medium and MMP‐9 expression was also observed. © 2009 UICC

[1]  J. Keski‐Oja,et al.  Secretion of active membrane type 1 matrix metalloproteinase (MMP‐14) into extracellular space in microvesicular exosomes , 2008, Journal of cellular biochemistry.

[2]  S. Wiseman,et al.  Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. , 2008, Cancer research.

[3]  M. Ebert,et al.  Caveats of caveolin-1 in cancer progression. , 2008, Cancer letters.

[4]  M. Biffoni,et al.  The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. , 2008, Cancer research.

[5]  V. Torres,et al.  Caveolin-1: an ambiguous partner in cell signalling and cancer , 2008, Journal of cellular and molecular medicine.

[6]  J. Hsieh,et al.  Caveolin‐1 secreting LNCaP cells induce tumor growth of caveolin‐1 negative LNCaP cells in vivo , 2008, International journal of cancer.

[7]  T. Thompson,et al.  Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. , 2008, Cancer research.

[8]  M. Shatz,et al.  Caveolin-1: A tumor-promoting role in human cancer , 2008, International journal of radiation biology.

[9]  J. Hancock,et al.  Reassessing the Role of Phosphocaveolin‐1 in Cell Adhesion and Migration , 2007, Traffic.

[10]  D. Rodriguez,et al.  E-Cadherin Is Required for Caveolin-1-Mediated Down-Regulation of the Inhibitor of Apoptosis Protein Survivin via Reduced β-Catenin-Tcf/Lef-Dependent Transcription , 2007, Molecular and Cellular Biology.

[11]  Marta C Guadamillas,et al.  Integrin regulation of caveolin function , 2007, Journal of cellular and molecular medicine.

[12]  N. Sawada,et al.  Caveolin-1 in extracellular matrix vesicles secreted from osteoblasts. , 2007, Bone.

[13]  Yair Lotan,et al.  Caveolin‐1 overexpression is associated with aggressive prostate cancer recurrence , 2007, The Prostate.

[14]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[15]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[16]  C. Peschle,et al.  TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway , 2006, Journal of Cell Science.

[17]  H. Rui,et al.  Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. , 2006, The American journal of pathology.

[18]  T. Wheeler,et al.  Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort , 2006, Clinical Cancer Research.

[19]  J. Xiang,et al.  Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. , 2006, Experimental oncology.

[20]  T. Wheeler,et al.  Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. , 2006, Cancer research.

[21]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[22]  Richard G. W. Anderson,et al.  Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization , 2005, Nature Cell Biology.

[23]  M. Lisanti,et al.  Caveolin-1 in oncogenic transformation, cancer, and metastasis. , 2005, American journal of physiology. Cell physiology.

[24]  John N. Hutchinson,et al.  Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo , 2004, Journal of Biological Chemistry.

[25]  M. Parat,et al.  A role for caveolae in cell migration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  A. Llorente,et al.  Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line , 2004, Journal of Cell Science.

[27]  A. Carè,et al.  Role of PLZF in melanoma progression , 2004, Oncogene.

[28]  N. Ahmed,et al.  Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the β6 integrin subunit , 2002, International journal of cancer.

[29]  Veronica Huber,et al.  Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles , 2002, The Journal of experimental medicine.

[30]  G. Fiucci,et al.  Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells , 2002, Oncogene.

[31]  M. Ittmann,et al.  Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. , 2001, Cancer research.

[32]  L. Coussens,et al.  Extrinsic regulators of epithelial tumor progression: metalloproteinases. , 2000, Current opinion in genetics & development.

[33]  Richard G. W. Anderson,et al.  Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells , 1999, Nature Cell Biology.

[34]  Charles C. Wykoff,et al.  Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth* , 1997, The Journal of Biological Chemistry.

[35]  A. Carè,et al.  HOXB7 constitutively activates basic fibroblast growth factor in melanomas , 1996, Molecular and cellular biology.

[36]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[37]  J. Glenney Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. , 1989, The Journal of biological chemistry.

[38]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[39]  D. Hoekstra,et al.  Fluorescence method for measuring the kinetics of fusion between biological membranes. , 1984, Biochemistry.

[40]  M. Bar‐eli,et al.  Transcriptional regulation of metastasis-related genes in human melanoma , 2004, Clinical & Experimental Metastasis.

[41]  A. Baldi,et al.  Expression of AP‐2 transcription factor and of its downstream target genes c‐kit, E‐cadherin and p21 in human cutaneous melanoma , 2001, Journal of cellular biochemistry.